These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 28285934)

  • 21. Applying the skin sensitisation adverse outcome pathway (AOP) to quantitative risk assessment.
    Maxwell G; MacKay C; Cubberley R; Davies M; Gellatly N; Glavin S; Gouin T; Jacquoilleot S; Moore C; Pendlington R; Saib O; Sheffield D; Stark R; Summerfield V
    Toxicol In Vitro; 2014 Feb; 28(1):8-12. PubMed ID: 24184331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemical mixtures: current risk assessment methodologies and future directions.
    Seed J; Brown RP; Olin SS; Foran JA
    Regul Toxicol Pharmacol; 1995 Aug; 22(1):76-94. PubMed ID: 7494906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Informing 21st-Century Risk Assessments with 21st-Century Science.
    Birnbaum LS; Burke TA; Jones JJ
    Environ Health Perspect; 2016 Apr; 124(4):A60-3. PubMed ID: 27035154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated approaches for the analysis of toxicologic interactions of chemical mixtures.
    el-Masri HA; Reardon KF; Yang RS
    Crit Rev Toxicol; 1997 Mar; 27(2):175-97. PubMed ID: 9099518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving the scientific foundation for mixtures joint toxicity and risk assessment: contributions from the SOT mixtures project--introduction.
    Mason AM; Borgert CJ; Bus JS; Moiz Mumtaz M; Simmons JE; Sipes IG;
    Toxicol Appl Pharmacol; 2007 Sep; 223(2):99-103. PubMed ID: 17434550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The long and winding road of progress in the use of in vitro data for risk assessment purposes: From "carnation test" to integrated testing strategies.
    Blaauboer BJ
    Toxicology; 2015 Jun; 332():4-7. PubMed ID: 24769060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gaining acceptance for the use of in vitro toxicity assays and QIVIVE in regulatory risk assessment.
    Meek ME; Lipscomb JC
    Toxicology; 2015 Jun; 332():112-23. PubMed ID: 25598226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxicological evaluation of chemical mixtures.
    Feron VJ; Groten JP
    Food Chem Toxicol; 2002 Jun; 40(6):825-39. PubMed ID: 11983277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The development of computational toxicology and application in risk assessment of chemicals].
    Zhang R; Chen W
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Aug; 53(8):843-850. PubMed ID: 31378047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Precision of estimates of an ADI (or TDI or PTWI).
    Speijers GJ
    Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S87-93. PubMed ID: 10597619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicity testing in the 21st century: progress in the past decade and future perspectives.
    Krewski D; Andersen ME; Tyshenko MG; Krishnan K; Hartung T; Boekelheide K; Wambaugh JF; Jones D; Whelan M; Thomas R; Yauk C; Barton-Maclaren T; Cote I
    Arch Toxicol; 2020 Jan; 94(1):1-58. PubMed ID: 31848664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges to environmental toxicology and epidemiology: where do we stand and which way do we go?
    Pesch B; Brüning T; Frentzel-Beyme R; Johnen G; Harth V; Hoffmann W; Ko Y; Ranft U; Traugott UG; Thier R; Taeger D; Bolt HM
    Toxicol Lett; 2004 Jun; 151(1):255-66. PubMed ID: 15177661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human biomonitoring as a pragmatic tool to support health risk management of chemicals--examples under the EU REACH programme.
    Boogaard PJ; Hays SM; Aylward LL
    Regul Toxicol Pharmacol; 2011 Feb; 59(1):125-32. PubMed ID: 20933039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integration of epidemiological findings with mechanistic evidence in regulatory pesticide risk assessment: EFSA experiences.
    Pelkonen O; Bennekou SH; Crivellente F; Terron A; Hernandez AF
    Arch Toxicol; 2019 Jun; 93(6):1779-1788. PubMed ID: 31053889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deciding which chemical mixtures risk assessment methods work best for what mixtures.
    Teuschler LK
    Toxicol Appl Pharmacol; 2007 Sep; 223(2):139-47. PubMed ID: 16997340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utilizing relative potency factors (RPF) and threshold of toxicological concern (TTC) concepts to assess hazard and human risk assessment profiles of environmental metabolites: a case study.
    Terry C; Rasoulpour RJ; Knowles S; Billington R
    Regul Toxicol Pharmacol; 2015 Mar; 71(2):301-17. PubMed ID: 25584438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Methods in the assessment of combined effect of substances].
    Zholdakova ZI; Kharchevnikova NV; Mamonov RA; Sinitsyna OO
    Gig Sanit; 2012; (2):86-9. PubMed ID: 22834277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse outcome pathway development from protein alkylation to liver fibrosis.
    Horvat T; Landesmann B; Lostia A; Vinken M; Munn S; Whelan M
    Arch Toxicol; 2017 Apr; 91(4):1523-1543. PubMed ID: 27542122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Impact of Novel Assessment Methodologies in Toxicology on Green Chemistry and Chemical Alternatives.
    Rusyn I; Greene N
    Toxicol Sci; 2018 Feb; 161(2):276-284. PubMed ID: 29378069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of omics data in regulatory toxicology: report of an international BfR expert workshop.
    Marx-Stoelting P; Braeuning A; Buhrke T; Lampen A; Niemann L; Oelgeschlaeger M; Rieke S; Schmidt F; Heise T; Pfeil R; Solecki R
    Arch Toxicol; 2015 Nov; 89(11):2177-84. PubMed ID: 26486796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.